EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS Trademark Information

Boehringer Ingelheim International GmbH

Medical and scientific research in the field of diabetes, cardiovascular diseases and chronic kidney disease; Providing medical and scientific research information in the field of diabetes, cardiovascular diseases and chronic kidney disease

Words that describe this mark

medical   scientific   research   field   diabetes     cardiovascular   diseases   chronic   kidney   disease   providing   medical   scientific   research   information   field   diabetes     cardiovascular   diseases   chronic   kidney   disease  

This is a brand page for the EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS trademark by Boehringer Ingelheim International GmbH  in , , .

Write a review about a product or service associated with this EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS trademark. Or, contact the owner Boehringer Ingelheim International GmbH of the EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS trademark.

On Friday, September 28, 2018, a U.S. federal trademark registration was filed for EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS. The USPTO has given the EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS trademark serial number of 79249526. The current federal status of this trademark filing is REGISTERED. The correspondent listed for EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS is Martin J. Beran of Ostrolenk Faber LLP, 845 Third Avenue, 8th Floor, New York, NY 10022 . The EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS trademark is filed in the category of Computer & Software Services & Scientific Services . The description provided to the USPTO for EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS is Medical and scientific research in the field of diabetes, cardiovascular diseases and chronic kidney disease; Providing medical and scientific research information in the field of diabetes, cardiovascular diseases and chronic kidney disease.

Word mark: EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS
Status/Status Date:
REGISTERED
7/2/2019
Serial Number: 79249526
Filing Date: 9/28/2018
Registration Number: 5791084
Registration Date: 7/2/2019
Goods and Services: Medical and scientific research in the field of diabetes, cardiovascular diseases and chronic kidney disease; Providing medical and scientific research information in the field of diabetes, cardiovascular diseases and chronic kidney disease
Mark Description: The mark consists of the wording "EMPRISE" in black font. Below this is the wording "EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS" in blue. To the right of the wording is a red heart with magnifying glass covering the upper right portion of the heart. The magnifying glass is white and the lens of the magnifying glass is purple. Inside the lens is a stylized outline of a globe that transitions from white to purple from right to left. The color white appearing elsewhere in the mark is for background purposes only and is not claimed as a feature of the mark.
Type Of Mark: Service Mark
Published For Opposition Date: 4/16/2019
Last Applicant/Owner: Boehringer Ingelheim International GmbH
Mark Drawing Code: Drawing/Design + Words
Design Search:
Globes with meridians and parallel lines only (Celestial bodies, Natural phenomena, Geographical maps - Globes) see more design...
Hearts used as background or carriers (Human Beings - Parts of the human body, skeletons, skulls) see more design...
Magnifying glasses, jeweler's loupes (Telecommunications, sound recording or reproduction equipment; photography, cinematography and optics - Photography, cinematography, optics) see more design...
Register Type: Principal
Disclaimer: ("EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS")
Correspondent:
Ostrolenk Faber LLP
845 Third Avenue, 8th Floor
New York, NY 10022

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $199/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
7/2/2019
REGISTERED
Correspondent Search:

Martin J. Beran is a correspondent of EMPRISE EMPAGLIFLOZIN REAL-WORLD EFFECTIVENESS trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: